Selective ablation of TRA-1-60+ pluripotent stem cells suppresses tumor growth of prostate cancer is a research paper published in Theranostics (2023). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: T32 CA009531
NCI NIH HHS
Grant: P30 CA022453
Intramural NIH HHS
Grant: ZIA BC011800
NCI NIH HHS
Grant: R37 CA220482
NCI NIH HHS
Grant: R01 CA229535
National Institutes of Health
Grant: 5R37CA220482-02
Delineating Functional Immunity via Image-Guided PET
National Institutes of Health
Grant: 3P30CA022453-37S2
Cancer Center Support Grant
National Institutes of Health
Grant: 2T32CA009531-21
Training Program in the Biology of Cancer
National Institutes of Health
Grant: 5R01CA229535-05
Novel role of APOBEC3 enzymes as key mediators of cisplatin sensitivity through aberrant processing of interstrand crosslinks
FWCI
0.50
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals